Our Speakers

Learn about the latest in addiction treatment and recovery tools and techniques from leading experts across the addiction health spectrum.

2021 Speakers

ON OUR AGENDA

U.S. Cannabis Policy
Friday, October 15
2:30PM – 3:30PM

Kevin A. Sabet, PHD

Keynote Speaker

An affiliate of the Institution for Social and Policy Studies and the Medical School at Yale University, and dubbed by NBC News as the “prodigy of drug politics,” author, consultant, and advisor to three U.S. presidential administrations, and assistant professor, Kevin A. Sabet, Ph.D., has studied, researched, written about, and implemented drug policy for more than 25 years. He is currently the President and CEO of SAM (Smart Approaches to Marijuana), a non-profit organization he founded with Congressman Patrick Kennedy and David Frum. His first book, Reefer Sanity: Seven Great Myths About Marijuana, was published by Beaufort (Midpoint) in 2013, and its second edition released in 2018. He is also the co-editor of Marijuana and Contemporary Health, published by Oxford University Press and an institute director at the University of Florida.

His latest book, Smokescreen: What the Marijuana Industry Doesn’t Want You to Know, was distributed by Simon & Schuster in April, 2021 and released to critical acclaim.

His work as a government advisor began in the Clinton Administration as a researcher, and he was the senior speechwriter on drug policy in the Bush Administration (2002-2003). He returned to government in 2009, where he was asked to assist in drafting President Obama’s National Drug Control Strategy as a senior advisor. In 2011, he stepped down after being the only drug policy staffer to have served as a political appointee in a Democrat and Republican administration.

He has since been profiled in Politico, Crain’s Business, Salon Magazine, the International Business Times, The Daily Beast, Vox, and many other publications as America’s point person on drug policy issues. He has spoken at the Allen and Co. Sun Valley Conference, the Aspen Ideas, New Yorker, and Politicon festivals, at the Puebla Ideas Conference to debate the former presidents of Mexico and Colombia, on the Organization of American States blue ribbon commission advising hemispheric drug policy, and in hundreds of forums and discussions. He has been featured on the front page of the New York Times and in virtually every major media publication and news channel on the subject of drug policy. He has published op-eds in the Washington Post, New York Times, Los Angeles Times, and dozens of other publications. Dr. Sabet’s regular blog is housed at the Huffington Post and two of his op-eds have earned him a “Five Best Columns” distinction by The Atlantic.

Dr. Sabet also regularly advises foreign governments, several non-governmental organizations working to reduce drug abuse and its consequences, and serves in an international role as an advisor, in various capacities, to the United Nations and other multi-national organizations.

He is the winner of numerous drug policy awards, including the 2014 Nils Bejerot Award for Global Drug Prevention, given at Stockholm City Hall by the anti-drug organization chaired by H.M. Queen Silvia of Sweden, the 2019 National Narcotics Lifetime Achievement Award, and the John P. McGovern Award for Drug Prevention given by the Institute for Behavior and Health, and Robert DuPont, the founding director of the National Institute on Drug Abuse.

He received his Doctorate of Philosophy and Masters of Science from Oxford University as a Marshall Scholar in 2007 and 2002, respectively, and his B.A. with high honors in Political Science from the University of California, Berkeley in 2001.

 

ON OUR AGENDA

Ilene Robeck MD: Buprenorphine Innovations
Friday, October 15
1:00PM – 2:00PM

 

Ilene Robeck, M.D.

Ilene Robeck received her BA in English from SUNY at Buffalo and received her MD from SUNY at Buffalo Medical School. She did her internal medicine residency at Georgetown University. She was Chief Medical Resident at Fairfax Hospital, a Georgetown University-affiliated tertiary care center from 1980-1981. At that time she also participated in the hospital Medical-Psychiatric Liaison Fellowship Program.

She taught internal medicine on the Georgetown University Medical Service at DC General Hospital from 1981 to 1982 She was medical director and following that education director of Comprehensive Addiction Treatment Services from 1982-1992. She became board certified in addiction medicine in 1990. She launched an internal medicine private practice and also did consultative work in pain management and addiction medicine from 1985-2007.

She began working at the James A. Haley VA Hospital in Tampa in 2007 and established and was section chief of 1.the post-deployment primary care clinic and 2. a high-risk chronic pain clinic embedded in primary care for patients with comorbid pain with addiction and/or psychiatric problems and/or complex medical problems. In 2010 she became Chair of the National VA Primary Care Pain Champions Initiative.

In 2010 she transferred to the Bay Pines VA Health Care System. While at the Bay Pines VA she developed a consulting program doing electronic consulting for patients with chronic pain and an educational program geared for primary care and mental health providers. In addition, she did pain consultation for the buprenorphine/naloxone program, the residential substance abuse treatment program, the PTSD program, the domiciliary program for homeless veterans, the inpatient units, and the emergency department. She met regularly with the buprenorphine/naloxone clinic staff and patients. In addition, she had weekly groups with the residential substance use disorder patients.

In 2013 she became director of virtual pain care for the Richmond VAMC. In this capacity, she produced 2 case-based webinar programs each week, did consults, and saw patients throughout the country using clinical video teleconsulting.

In her work as chair of the national VA Primary Care Pain Champions Initiative, her role included national education and consultation with primary care programs looking to improve their approach to pain care in the primary care setting as well as consulted with facilities to improve the approach to high-risk chronic pain patients through the development of high-risk pain clinics. She also worked with pharmacy, substance use disorder, pain, mental health, and academic detailing clinicians to improve pain care options and education for clinicians and patients. While with the VA she was editor of the Opioid Safety Section of the VA pain website. She was one of the VA authors on the revised VA/DoD Opioid Clinical Practiced Guidelines published in 2017.

She is the lead editor for the ASAM Pain and Addiction Manual published in 2018. She currently is an educational consultant in areas related to pain and/or addiction for the DoD. She is the medical interest group lead for the Association of Senior Professionals at Eckerd College and the lead for the medical team of the St. Petersburg League of Women Voters.

Throughout her career, she had lectured and written on topics such as pain management, mental health concerns in the primary care setting, the high-risk chronic pain patient, and addiction diagnosis/treatment. Once joining the VA she also wrote and lectured about post-deployment concerns in the returning veteran. She has been on the faculty and lectured for the American Society of Addiction Medicine annual course on pain and addiction. She is the lead editor for the ASAM Manual on Pain and Addiction.

Since retiring from the VA she continues as an educational consultant for the Walter Reed National Military Medical Center putting together twice monthly webinars on pain as well as addiction. Upon her retirement from the VA, she has become more active in multiple community organizations including ASPEC, The St. Petersburg Free Clinic, and the League of Women Voters.

ON OUR AGENDA

3rd Wave of the Opioid Epidemic
Saturday, October 16
8:00AM – 9:00AM

Dr. Jason Fields

Dr. Jason Fields has been practicing addiction medicine for about 10 years. He was a general pediatrician in North Carolina and started a second career in addictions here in Florida in 2011. Dr. Fields did a fellowship in addiction medicine with the University of Florida Addiction Medicine program from 2011 to 2013 while working at DACCO, a community treatment center in east Hillsborough County. He has been board certified in addiction medicine since 2012. He went on to become the medical director at DACCO and has experience working in both outpatient and residential substance use treatment centers. In 2019 he joined the BayCare Behavioral Health Team to bring best practice addiction medicine to the organization. He enjoys community outreach and does education in the community on best practice medication-assisted treatment for opioid use disorder as a peer mentor with both FADAA and DCF. Dr. Fields has served as President of the Florida Society of Addiction Medicine and is currently serving as Treasurer on this board.

 

ON OUR AGENDA

Alcohol, the Other Epidemic, in a Pandemic
Saturday, October 16
9:00AM – 10:00AM

Dr. William Greene

Dr. Greene graduated from Wake Forest University with a bachelor’s degree in biology. He completed medical school at the University of South Florida, and his residency in general psychiatry at the University of Florida. He went on to complete a fellowship in Addiction Medicine at the University of Florida as well. In 2007, Dr. Greene joined the University of Florida College of Medicine faculty, as an Assistant Professor in the Department of Psychiatry, Division of Addiction Medicine. He currently serves as Medical Director of the 18-bed Dual Disorders Unit at UF Health Shands Psychiatric Hospital. In 2017, Dr. Greene was promoted to Associate Professor. Dr. Greene serves many roles, including performing independent medical evaluations for safety-sensitive professionals. He also plays a key role in the education of fellows and medical students and is the current Associate Program Director for the ACGME Addiction Medicine fellowship. Dr. Greene is board certified in Addiction Medicine by the American Board of Preventive Medicine, and in Psychiatry by the American Board of Psychiatry and Neurology.

 

ON OUR AGENDA

COVID-19 Behavioral and Mental Health Challenges
Saturday, October 16
10:25AM – 11:25AM

Bernd Wollschlaeger, M.D.

Bernd Wollschlaeger, MD, FAAFP,FASAM is a board-certified family physician, and addiction specialist in private practice, Fellow of the American Academy of Family Physicians and the American Society of Addiction Medicine. He received his medical training in Germany and Israel, served as a physician in the Israel Defense Forces, completed his residency training at Jackson Memorial Hospital, Miami, FL and was a chief resident. He also serves as a clinical preceptor for medical students from the Florida International and Florida State University and is the Past President of the Florida Society of Addiction Medicine.
In 2009 Governor Crist appointed him as a member of the Prescription Drug Monitoring Program Implementation and Oversight Taskforce. From 2010 -2011 he served as a member of the Miami-Dade County Addiction Services Board.
Dr. Wollschlaeger is a passionate advocate for mental health parity, substance abuse treatment and public health issues and published dozens of peer reviewed articles and several book chapters related to the diagnosis and management of substance use disorder.

 

ON OUR AGENDA

Personal Digital Technology and Recovery
Saturday, October 16
1:30PM – 2:30PM

Yuri Maricich, M.D., MBA

Dr. Maricich leads the Clinical/Regulatory/Quality and Medical Affairs group at Pear Therapeutics as the Chief Medical Officer and Head of Development. He leads and manages the development programs from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission and review as well as Medical Affairs. In addition to overseeing subsequent pipeline programs across a broad-spectrum of disease areas (such as CNS/neuroscience, cardiovascular, and oncology), he led reSET (1st prescription digital therapeutic) and reSET-O (1st combination drug and software treatment) programs.

Dr. Maricich is a licensed, board-certified physician, investor, clinical developer and strategist. He works to improve patient health and our healthcare system by investing in, advising, and providing leadership at innovative firms. He has worked with and led successful teams and programs at Healthcare & Life Science/biotech (HLS) firms, including Corixa (acquired by GlaxoSmithKline), Xdynia (acquired by Cavion), Cavion (acquired by Jazz Pharmaceuticals), AWS, and Pear Therapeutics (1st FDA-cleared, clinically validated digital therapeutic to treat disease). He founded a digital health firm while a med student that used AI and NLP to structure clinical data.

Dr. Maricich completed his education and training at Harvard University, the University of Washington, the University of Notre Dame, and the University of Virginia. 

 

ON OUR AGENDA

Professional Monitoring Challenges
Saturday, October 16
2:30PM − 3:30PM

John C. Tanner

  • Medical Director for the Intervention Project for Nurses (IPN) – Florida
  • Former Assistant Medical Director for Professional’s Resource Network (PRN)
  • Assistant Professor, Department of Psychiatry, University of Florida College of Medicine (currently a courtesy appointment)
  • Part-time private Addiction and Behavioral Medicine practice since 1984
  • Medical Director Tides Edge (a detox and residential treatment facility)
  • Former Director at Large for the American Society of Addiction Medicine’s Board of Directors for consecutive terms (from 2011 to March 2019)
  • Distinguished Fellow of the American Society of Addiction Medicine (DFASAM)
  • Fellow of the American Osteopathic Academy of Addiction Medicine (FAOAAM)
  • Currently serving on the Board of Directors for the Florida Society of Addiction Medicine since 2013
  • Inaugural Diplomate of The American Board of Addiction Medicine (DABAM)
  • One of the 3 Principle Investigators for the FDA Phase 2 and 3 Clinical Trials for approval of Suboxone® Film
  • Certified Medical Review Officer (MRO) by the Medical Review Officer Certification Council
  • Clinically Certified Forensic Counselor (CCFC) and Diplomate of The Board of Clinical Forensic Counseling
  • Certificate of Added Qualifications in Addiction Medicine by the AOA Bureau of Osteopathic Specialists under the
  • Conjoined Boards
  • Honored as selection for the 2019 “Legend” of The Beaches Award representing the beach communities from Atlantic
  • Beach down to Ponte Vedra and Palm Valley

 

ON OUR AGENDA

Drug Testing Developments and Clinical Implications
Saturday, October 16
3:45PM – 4:45PM

Scott Teitelbaum, M.D.

Scott Teitelbaum, M.D., is the Pottash Professor in Psychiatry and Neuroscience at the University of Florida’s College of Medicine, where he serves as Vice Chair of the Department of Psychiatry, Chief of the Division of Addiction Medicine, Medical Director of the UF Health Florida Recovery Center, and Fellowship Director of UF’s American Board of Preventative Medicine (ABPM) – Addiction fellowship.

Originally trained and board-certified as a pediatrician, Dr. Teitelbaum later completed fellowships in addiction medicine and child psychiatry at the University of Florida. Dr. Teitelbaum became medical director of the Florida Recovery Center in 2002, and since then has been involved in the evaluation and/or treatment of more than 4,000 healthcare providers and other professionals from across the country. Through his efforts, the Florida Recovery Center has led the way nationally with its evidence-based treatment of the disease of addiction.

Dr. Teitelbaum developed one of the first-ever accredited fellowships in addiction medicine. His program now has trained more addiction-medicine fellows than any other program nationwide. In 2016, Dr. Teitelbaum was awarded the Pottash Endowment, allowing for the creation of a research initiative that’s focused on addiction medicine and the fight toward recovery. He has been honored on multiple occasions with the Exemplary Teacher Award for his guidance of medical students.

Dr. Teitelbaum has received multiple awards and honors, including in January 2018, the American Society of Addiction Medicine named Dr. Teitelbaum winner of its Prestigious Annual Award in recognition of his outstanding contributions to the field.

A national expert who has been consulted by the White House Office of National Drug Control and the U.S. Drug Enforcement Administration, Dr. Teitelbaum is passionate about reducing stigma and advancing treatment for those suffering from the disease of addiction.

 

ON OUR AGENDA

Recovery Yoga
Sunday, October 17
8:00AM – 9:00AM

Kimberly Simo

Kimberly Simon has served with the Florida Professionals Resource Network for several years, currently as the Intake Coordinator, and is a Registered Yoga Teacher (RYT), 200-hour, with Yoga Alliance. She received her yoga teacher training at Centred on Yoga in Fernandina Beach, Florida, where she learned meditation and Baptiste-inspired gentle and power flows and is currently working toward her 500-hour RYT with Asheville Yoga Center. Kimberly has received additional training and is currently teaching trauma-informed classes primarily in mental health and addiction treatment centers with the nonprofit, Yoga 4 Change, which provides a purpose-driven yoga curriculum to vulnerable youth, military veterans, incarcerated individuals, and those living with mental health and/or substance use conditions. Kimberly is looking forward to sharing the gifts that come from the practice of yoga both on and off of the mat.